Sat.Nov 09, 2024 - Fri.Nov 15, 2024

article thumbnail

How the Inflation Reduction Act Will Impact Pharmacy Reimbursement | ASPL 2024

Drug Topics

Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.

112
112
article thumbnail

The Pharmacy Model Is Changing

Pharmacy Times

Embracing artificial intelligence and other tools will be necessary to push the field forward.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: How Pfizer used wearables to tap into the promise of an experimental drug

STAT

Pfizer’s promising research on a treatment for a dangerous cancer-related condition is also helping prove out the value of wearables in clinical trials. In September, the pharma giant reported results showing that an experimental antibody could positively impact people with cachexia, a complication sometimes called “wasting syndrome” that can cause people with cancer to lose weight and make it harder for them to tolerate treatments.

140
140
article thumbnail

Primary care player Forward shutters after raising $400M, rolling out CarePods

Fierce Healthcare

Primary care player Forward is abruptly shutting down its operations, closing its locations and canceling scheduled visits, the company publicly announced Wednesday. | Primary care player Forward is abruptly shutting down its operations, closing its locations and canceling scheduled visits, the company publicly announced Wednesday.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Q&A: Common Reasons Independent Pharmacies Face PBM Audits

Drug Topics

A conversation with Trent Thiede, PharmD, MBA, president of PAAS National, at NCPA 2024.

article thumbnail

Insights on Innovation: Craig Beavers Previews AHA 2024 and Emerging Trends in Cardiovascular Care

Pharmacy Times

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP will be moderating a session about social determinants of health and heart failure.

145
145

More Trending

article thumbnail

Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers

Fierce Healthcare

Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.

142
142
article thumbnail

Drug Shortages are Impacting Patient Care, Pharmacy Resources

Drug Topics

A conversation with Michael Ganio, PharmD, BCPS, FASHP, senior director of Pharmacy Practice and Quality at ASHP.

article thumbnail

FDA Approves Eladocagene Exuparvovec-Tneq for Treatment of AADC Deficiency

Pharmacy Times

Eladocagene exuparvovec-tneq is the first FDA-approved gene therapy for with aromatic L-amino acid decarboxylase deficiency.

FDA 144
article thumbnail

The recovery community says it offers refuge from opioid addiction. But it’s still hostile to lifesaving addiction medications 

STAT

The last time Mark Palinski went to a Narcotics Anonymous meeting, he was asked to leave and never come back. He stills remembers the argument: All he had done was advocate for the use of the “gold standard” treatment opioid addiction, a common medication called buprenorphine.  To Palinski, buprenorphine is a godsend.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The evolving role of AI in drug submission and approval: An expert perspective

pharmaphorum

Discover an expert perspective on how artificial intelligence is transforming the drug submission and approval process in the pharmaceutical industry. Explore the evolving role of AI in drug development.

127
127
article thumbnail

Community Pharmacists Crucial in RSV Vaccine Education Efforts

Drug Topics

After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.

Vaccines 187
article thumbnail

What Will Happen if Millions of Americans Lose Access to GLP-1s at the Same Time?

Pharmacy Times

There has never been such widespread and popularized use of compounded products due to shortages. Will consumers rise up with pitchforks if the party is shut down?

article thumbnail

OpenAI isn’t built for health care. So why is its tech already in hospitals, pharma, and cancer care?

STAT

The company behind ChatGPT didn’t set out to tackle health care.

Hospitals 131
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years

Fierce Pharma

Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years fkansteiner Wed, 11/13/2024 - 14:37

125
125
article thumbnail

Specialty Pharmacist Transforms HIV Care Outside of the Pharmacy

Drug Topics

Cassandra Esperant, PharmD, AAHIVP, discussed the ups and downs of her career journey as a clinical HIV pharmacist.

187
187
article thumbnail

Overcoming Failure as a Recent Pharmacy Graduate

Pharmacy Times

Failing is not final, and it does not define what kind of pharmacist or resident a student can be.

144
144
article thumbnail

Major payers saw mixed results in Q3. Here's a look at how each fared

Fierce Healthcare

The third quarter of 2023 was another mixed bag for major insurers as they continue to grapple with significant headwinds. | The third quarter of 2023 was another mixed bag for major insurers as they continue to grapple with significant headwinds.

Insurance 127
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Spravato is just the beginning in a new wave of depression meds

PharmaVoice

Psychiatry is getting more targeted as drugmakers develop a new range of treatments for depression.

126
126
article thumbnail

Prescription Drugs in the US Must Be Viewed as Critical Infrastructure | ASPL 2024

Drug Topics

Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.

187
187
article thumbnail

FDA Approves Obecabtagene Autoleucel for Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Pharmacy Times

The regulatory approval corresponds with positive safety and efficacy data from the FELIX trial.

FDA 145
article thumbnail

AI tool spots long COVID in electronic health records

pharmaphorum

Mass General Brigham researchers have developed an AI that can spot hidden cases of long COVID from electronic health records

126
126
article thumbnail

Rula Health, Amazon Health team up to expand access to virtual mental healthcare

Fierce Healthcare

Rula Health has teamed up with Amazon Health Services to expand access to mental healthcare. | Amazon customers can search for mental health support using keywords like “stress relief” or “anxiety relief” to find providers who take their insurance and meet their needs. Rula is available via search, product detail pages or navigating the discovery bar.

Insurance 126
article thumbnail

Q&A: Educating Patients on Importance of Flu Vaccination

Drug Topics

Lauren Angelo, PharmD, MBA, discusses effective ways pharmacists can educate and encourage their communities on the importance of flu vaccination.

Vaccines 142
article thumbnail

Semaglutide Improves Liver Fibrosis in Patients with Metabolic Dysfunction-Associated Steatohepatitis

Pharmacy Times

Glucagon-like peptide-1 agonists have increasingly showed potential for treating liver fibrosis in patients, which disproportionately affects those who are overweight or have obesity.

145
145
article thumbnail

In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex

Fierce Pharma

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks to a key patient survival win.

122
122
article thumbnail

STAT+: FDA is still struggling with a lack of inspectors, but doesn’t have a plan, watchdog finds

STAT

In the wake of the Covid-19 pandemic, the Food and Drug Administration continues to struggle with a lack of investigators needed to inspect domestic and foreign pharmaceutical manufacturing plants and has not yet developed a plan to keep needed staff, a U.S. government watchdog found. Between November 2021 and this past June, the vacancy rate among investigators increased to 16% from 9%.

FDA 122
article thumbnail

Cardinal Health inks two deals worth $3.9B to expand diabetes, gastroenterology businesses

Fierce Healthcare

Cardinal Health plans to buy two companies that will expand its diabetes and gastroenterology businesses as part of an overall strategy to grow its footprint in specialty medicine. | Cardinal Health plans to buy two companies that will expand its diabetes and gastroenterology businesses as part of an overall strategy to grow its footprint in specialty medicine.

123
123
article thumbnail

FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia

Pharmacy Times

The indication is for adult and pediatric patients 1 year and older with a lysine methyltransferase 2A gene translocation.

FDA 139
article thumbnail

EMA changes tack, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population

Fierce Pharma

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | Upon reexamination, the EMA has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. But the recommendation for approval has a restriction.

117
117
article thumbnail

STAT+: FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus

STAT

The Food and Drug Administration has scolded Merz Pharmaceutical for making misleading claims on Instagram about the safety and effectiveness of an injectable treatment for smoothing facial lines, the fifth time this year the agency has taken a pharmaceutical company to task for its marketing. The regulator criticized Merz for a few reasons concerning Xeomin, which is promoted as an alternative to Botox for combating wrinkle and frown lines.

FDA 119
article thumbnail

Fierce Health Payer Summit, Day 1: Opportunities and challenges for insurers in 2025

Fierce Healthcare

AUSTIN, Texas—The second annual Fierce Health Payer Summit kicked off Wednesday to tackle the most pressing issues facing health plan leaders. | AUSTIN, Texas—On Day 1 of the Fierce Health Payer Summit, panelists discussed the role of technology to retain members, trends in Medicare Advantage and changes to Medicare Part D.

Insurance 117
article thumbnail

Providers Prefer Increased Pneumonia, IPD Coverage and Lower Age Recommendation For Pneumococcal Vaccines

Pharmacy Times

Reasons for supporting the lowering of the age-based pneumococcal vaccine recommendation included the likelihood it would increase vaccination rates in multiple age groups and demographics.

Vaccines 145